Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
3(21%)
Results Posted
44%(4 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_1
9
64%
Ph phase_2
1
7%
Ph phase_3
1
7%
Ph not_applicable
3
21%

Phase Distribution

9

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
9(64.3%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(9)
Terminated(2)

Detailed Status

Completed9
Recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
81.8%
Most Advanced
Phase 3

Trials by Phase

Phase 19 (64.3%)
Phase 21 (7.1%)
Phase 31 (7.1%)
N/A3 (21.4%)

Trials by Status

recruiting321%
terminated214%
completed964%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT06504381Phase 1

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Recruiting
NCT05464667Not Applicable

Preoperative Irradiation for Stage I Breast Cancer

Recruiting
NCT04221893Not Applicable

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Recruiting
NCT02318771Phase 1

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Completed
NCT03437161Not Applicable

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation

Completed
NCT03367715Phase 2

Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Completed
NCT02768558Phase 3

Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC

Terminated
NCT00005092Phase 1

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Completed
NCT00004246Phase 1

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

Completed
NCT02297230Phase 1

Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

Terminated
NCT00578071Phase 1

Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer

Completed
NCT00631527Phase 1

Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer

Completed
NCT00004109Phase 1

Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

Completed
NCT00004123Phase 1

Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma

Completed

All 14 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
14